Metraipolis › archive › dc_288473fb6aee
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein — Europe PMC PMID:35524344
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35524344
- DOI
- 10.1111/bcp.15392
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T10:24:32.821Z
- SHA-256 of the archived text
f19eb0f3e6921dae092d1b190ba2cf7183e1488dbeb39b2e0656af267393b209- Stable URL of this page
https://metraipolis.com/documento/dc_288473fb6aee
How to cite
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein — Europe PMC PMID:35524344 — Europe PMC (en), https://europepmc.org/article/MED/35524344 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_288473fb6aee (Metraipolis archive dc_288473fb6aee, sha256 f19eb0f3e6921dae092d1b190ba2cf7183e1488dbeb39b2e0656af267393b209)
BibTeX
@misc{dc288473fb6aee,
title = {Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein — Europe PMC PMID:35524344},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35524344},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_288473fb6aee; sha256 f19eb0f3e6921dae092d1b190ba2cf7183e1488dbeb39b2e0656af267393b209},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35524344. Agents can read the archived copy with the MCP tool read_document.